Optimizing Antibiotic Dosing Regimens for the Treatment of Infection Caused by Carbapenem Resistant Enterobacteriaceae

NCT04516395 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Drug Resistance
Carbapenem-Resistant Enterobacteriaceae Infection
Sepsis
Septic Shock
Critical Illness
Clinical Outcomes
Treatment Outcomes

Interventions

OTHER: Combined antibiotic regimens
OTHER: Standard antibiotic regimens

Sponsor

Phramongkutklao College of Medicine and Hospital